FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Linda Jaber

Research Profile

Living Beings

Arabs

Disorders

Chemicals & Drugs

Geographic Areas

Concepts & Ideas

Co-author Network

Publications

TOP 3
Nicole R Pinelli; Arin S Jantz; Emily T Martin; Linda A Jaber
Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs.
Kathryn M Hurren; Thomas N Taylor; Linda A Jaber
Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alert.
Nicole R Pinelli; Linda A Jaber
Practices of Arab American patients with type 2 diabetes mellitus during Ramadan.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Linda Jaber (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Nicole R Pinelli; Arin S Jantz; Emily T Martin; Linda A Jaber
Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs.
The Journal of clinical endocrinology and metabolism 2011;96(10):E1680-3.
2011: Kathryn M Hurren; Thomas N Taylor; Linda A Jaber
Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alert.
Diabetes research and clinical practice 2011;93(1):49-55.
2011: Nicole R Pinelli; Linda A Jaber
Practices of Arab American patients with type 2 diabetes mellitus during Ramadan.
Journal of pharmacy practice 2011;24(2):211-5.
2011: Linda A Jaber; Nicole R Pinelli; Morton B Brown; Martha M Funnell; Robert M Anderson; Adnan Hammad; William H Herman
Feasibility of group lifestyle intervention for diabetes prevention in Arab Americans.
Diabetes research and clinical practice 2011;91(3):307-15.
2011: Nicole R Pinelli; Arin Jantz; Zachary Smith; Amenah Abouhassan; Christina Ayar; Nadim A Jaber; Anthony W Clarke; Randall L Commissaris; Linda A Jaber
Effect of administration time of exenatide on satiety responses, blood glucose, and adverse events in healthy volunteers.
Journal of clinical pharmacology 2011;51(2):165-72.
2011: Nicole R Pinelli; Morton B Brown; William H Herman; Linda A Jaber
Family support is associated with success in achieving weight loss in a group lifestyle intervention for diabetes prevention in Arab Americans.
Ethnicity & disease 2011;21(4):480-4.
2010: Nicole R Pinelli; William H Herman; Morton B Brown; Linda A Jaber
Perceived risk and the willingness to enroll in a diabetes prevention lifestyle intervention in Arab-Americans.
Diabetes research and clinical practice 2010;90(2):e27-9.
2010: Nicole R Pinelli; Linda A Jaber; Morton B Brown; William H Herman
Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans.
Diabetes care 2010;33(6):1373-5.
2009: Nicole R Pinelli; Helen Doreen Berlie; Richard L Slaughter; Linda A Jaber
Risk perception for developing diabetes among pharmacists.
The Annals of pharmacotherapy 2009;43(6):1050-6.
2008: Nicole R Pinelli; Raymond Cha; Morton B Brown; Linda A Jaber
Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
The Annals of pharmacotherapy 2008;42(11):1541-51.
2008: Helen Doreen Berlie; William H Herman; Morton B Brown; Adnan Hammad; Linda A Jaber
Quality of diabetes care in Arab Americans.
Diabetes research and clinical practice 2008;79(2):249-55.
2007: Feng Chang; Linda A Jaber; Helen Doreen Berlie; Mary Beth O'Connell
Evolution of peroxisome proliferator-activated receptor agonists.
The Annals of pharmacotherapy 2007;41(6):973-83.
2007: Helen Doreen Berlie; James Kalus; Linda A Jaber
Thiazolidinediones and the risk of edema: a meta-analysis.
Diabetes research and clinical practice 2007;76(2):279-89.
2007: Helen Doreen Berlie; Adnan Hammad; Linda A Jaber
Health issues in the Arab American community. The use of glucose-lowering agents and aspirin among Arab Americans with diabetes.
Ethnicity & disease 2007;17(2 Suppl 3):S3-42-S3-45.
2007: May Darwish-Yassine; Linda A Jaber
Health issues in the Arab American community. Lifestyle and health outcomes. Overview.
Ethnicity & disease 2007;17(2 Suppl 3):S3-26-S3-27.
2006: Suha Al-Oballi Kridli; William H Herman; Morton B Brown; Haifa Fakhouri; Linda A Jaber
For the patient. Diabetes and its risk factors among Chaldean Americans.
Ethnicity & disease 2006;16(2):588.
2006: Suha Al-Oballi Kridli; William H Herman; Morton B Brown; Haifa Fakhouri; Linda A Jaber
The epidemiology of diabetes and its risk factors among Chaldean Americans.
Ethnicity & disease 2006;16(2):351-6.
2005: Suha Al-Oballi Kridli; William H Herman; Morton Brown; Haifa Fakhouri; Linda A Jaber
The epidemiology of diabetes and its risk factors among Chaldean Americans.
Ethnicity & disease 2005;15(1 Suppl 1):S1-30-1.
2005: Adnan Hammad; William H Herman; Linda A Jaber
Cardiovascular risk factors in an Arab-American population in southeastern Michigan.
Ethnicity & disease 2005;15(1 Suppl 1):S1-29.
2005: Linda A Jaber
Diabetes and the metabolic syndrome in Arab Americans: a community-based sample.
Ethnicity & disease 2005;15(1 Suppl 1):S1-26-8.
2004: Linda A Jaber; Morton B Brown; Adnan Hammad; Qian Zhu; William H Herman
The prevalence of the metabolic syndrome among arab americans.
Diabetes care 2004;27(1):234-8.
2003: Linda A Jaber; Morton B Brown; Adnan Hammad; Qian Zhu; William H Herman
Lack of acculturation is a risk factor for diabetes in arab immigrants in the US.
Diabetes care 2003;26(7):2010-4.
2003: Linda A Jaber
Barriers and strategies for research in Arab Americans.
Diabetes care 2003;26(2):514-5.
2003: Linda A Jaber; Morton B Brown; Adnan Hammad; Sandra N Nowak; Qian Zhu; Anisa Ghafoor; William H Herman
Epidemiology of diabetes among Arab Americans.
Diabetes care 2003;26(2):308-13.
2003: Sandra N Nowak; Linda A Jaber
Aspirin dose for prevention of cardiovascular disease in diabetics.
The Annals of pharmacotherapy 2003;37(1):116-21.
2002: Sandra N Nowak; David J Edwards; Anthony Clarke; Gail D Anderson; Linda A Jaber
Pioglitazone: effect on CYP3A4 activity.
Journal of clinical pharmacology 2002;42(12):1299-302.
2002: Sandra N Nowak; Renu Singh; Anthony Clarke; Everett Campbell; Linda A Jaber
Metabolic control and adherence to american diabetes association practice guidelines in a pharmacist-managed diabetes clinic.
Diabetes care 2002;25(8):1479.
2002: Linda A Jaber; Sandra N Nowak; Richard R Slaughter
Insulin-metformin combination therapy in obese patients with type 2 diabetes.
Journal of clinical pharmacology 2002;42(1):89-94.
1997: Gabriele E Sonnenberg; D C Garg; D J Weidler; R M Dixon; Linda A Jaber; A J Bowen; G S DeChemey; W S Mullican; L D Stonesifer
Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.
The Annals of pharmacotherapy 1997;31(6):671-6.
1997: H Halapy; Linda A Jaber
Diabetes management: follow-up.
The Annals of pharmacotherapy 1997;31(3):371.
1996: Linda A Jaber; M P Ducharme; David J Edwards; R L Slaughter; George Grunberger
The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
Pharmacotherapy 1996;16(5):760-8.
1996: Linda A Jaber; E J Antal; I R Welshman
Pharmacokinetics and pharmacodynamics of glyburide in young and elderly patients with non-insulin-dependent diabetes mellitus.
The Annals of pharmacotherapy 1996;30(5):472-5.
1996: Linda A Jaber; H Halapy; M Fernet; S Tummalapalli; H Diwakaran
Evaluation of a pharmaceutical care model on diabetes management.
The Annals of pharmacotherapy 1996;30(3):238-43.
1996: Linda A Jaber; M P Ducharme; H Halapy
The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.
Therapeutic drug monitoring 1996;18(1):6-13.
1996: W R Melchior; Linda A Jaber
Metformin: an antihyperglycemic agent for treatment of type II diabetes.
The Annals of pharmacotherapy 1996;30(2):158-64.
1995: P T Calissi; Linda A Jaber
Peripheral diabetic neuropathy: current concepts in treatment.
The Annals of pharmacotherapy 1995;29(7-8):769-77.
1995: Linda A Jaber; R L Slaughter; George Grunberger
Diabetes and related metabolic risk factors among Arab Americans.
The Annals of pharmacotherapy 1995;29(6):573-6.
1994: Linda A Jaber; E J Antal; R L Slaughter; I R Welshman
Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM.
Diabetes care 1994;17(11):1300-6.
1993: Linda A Jaber; N J Lewis; R L Slaughter; Anne Victoria Neale
The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy.
Journal of clinical pharmacology 1993;33(3):239-45.
1993: W R Melchior; V Bindlish; Linda A Jaber
Angiotensin-converting enzyme inhibitors in diabetic nephropathy.
The Annals of pharmacotherapy 1993;27(3):344-50.
1993: Linda A Jaber; E J Antal; R L Slaughter; I R Welshman
The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics.
European journal of clinical pharmacology 1993;45(5):459-63.
1992: Linda A Jaber; W R Melchior; D R Rutledge
Possible correlation between glycemia and blood pressure in black, diabetic, hypertensive patients.
The Annals of pharmacotherapy 1992;26(7-8):882-6.
1990: Linda A Jaber; N J Wenzloff; P Komanicky; E J Antal
An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizide.
Journal of clinical pharmacology 1990;30(2):181-8.
1989: Linda A Jaber; E M Bailey; Michael J Rybak
Enoxacin: a new fluoroquinolone.
Clinical pharmacy 1989;8(2):97-107.
1989: R Y Demers; Anne Victoria Neale; N J Wenzloff; K J Gronsman; Linda A Jaber
Glycosylated hemoglobin levels and self-reported stress in adults with diabetes.
Behavioral medicine (Washington, D.C.) 1989;15(4):167-72.